| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $60.3M | +5.2% |
| SG&A Expense | $28.7M | +116.5% |
| Operating Income | -$89.0M | -26.1% |
| Income Tax | $0 | — |
| Net Income | -$75.3M | -22.0% |
| EPS (Basic) | -$1.88 | +88.2% |
| EPS (Diluted) | -$1.88 | +88.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.5M | +54.7% |
| Current Assets | $241.4M | +59.9% |
| Total Assets | $326.0M | +75.5% |
| Current Liabilities | $11.7M | +12.4% |
| Total Liabilities | $19.1M | +0.1% |
| Stockholders' Equity | $306.8M | +287.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$66.3M | -25.6% |
| Capital Expenditures | $377K | +1296.3% |
| Investing Cash Flow | -$118.7M | +6.4% |
| Financing Cash Flow | $205.7M | +14.9% |
| Free Cash Flow | -$66.7M | -26.2% |